GS

Gyanendra Singh Baghel

Active Director Managing Director DIN 06707306
DIN 06707306 First appointment Nov 2013 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies –
Total affiliations 5 Since Nov 2013
Shareholding value •••• Premium profile

About Gyanendra Singh Baghel

Data last updated:

Gyanendra Singh Baghel has 12 years in corporate governance. Holds Managing Director and Director roles. Currently with 5 companies, including Xylam Remedies Private Limited and Protea Pharma Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹2.23 Cr; the largest is Gennext India Private Limited at ₹85.3 Lakh (FY 2025).

DIN 06707306
Primary Designation Managing Director
First Appointment 28 Nov 2013
Oldest Company Age 12 yrs
Largest company Gennext India Private Limited · ₹85.3 Lakh (FY 2025)
Combined revenue ₹2.23 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gennext India Private Limited U74999MP2016PTC040632
Director26 Apr 20162016₹85.3 Lakh (FY 2025)Active
Gyanvi Technologies Private Limited U72900MP2019PTC049727
Director04 Oct 20192019₹79.3 Lakh (FY 2024)Active
Xylam Remedies Private Limited U24100MP2013PTC031846
Managing Director28 Nov 20132013₹57.9 Lakh (FY 2025)Active
Protea Pharma Private Limited U24230MP2016PTC035562
Director25 Nov 20192016₹25,650 (FY 2017)Active
Rbf Empowerment Foundation U85499MP2025NPL078109
Director04 Aug 20252025–Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Xylam Remedies Private Limited
Protea Pharma Private Limited
Gyanvi Technologies Private Limited
Gennext India Private Limited
Premium access

Shareholding and investment profile for Gyanendra Singh Baghel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gyanendra Singh Baghel

Gyanendra Singh Baghel has 12 years in corporate governance. Holds Managing Director and Director roles. Currently with 5 companies, including Xylam Remedies Private Limited and Protea Pharma Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹2.23 Cr; the largest is Gennext India Private Limited at ₹85.3 Lakh (FY 2025).

Gyanendra Singh Baghel is associated with 5 companies as Managing Director and Director, including Gennext India Private Limited (₹85.3 Lakh), Gyanvi Technologies Private Limited (₹79.3 Lakh), Xylam Remedies Private Limited (₹57.9 Lakh).

Gyanendra Singh Baghel has expertise in General Business, Technology.

Gyanendra Singh Baghel has 12 years in corporate governance.

By reported revenue, the largest current company of Gyanendra Singh Baghel is Gennext India Private Limited, with revenue of ₹85.3 Lakh (FY 2025).

The 4 current companies of Gyanendra Singh Baghel that report revenue have a combined latest revenue of ₹2.23 Cr.

Gyanendra Singh Baghel currently holds positions at 5 companies: Gennext India Private Limited (₹85.3 Lakh), Gyanvi Technologies Private Limited (₹79.3 Lakh), Xylam Remedies Private Limited (₹57.9 Lakh), Protea Pharma Private Limited (₹25,650), Rbf Empowerment Foundation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available